Civic Intelligence

International Lymphoma Radiation Oncology Foundation

990EZ • Fiscal year 2016 • EIN 46-1995761

Jan 01, 2016 to Dec 31, 2016 • Filed on Jul 10, 2017

PO Box 810New York, NY 10021

(212) 639-5999

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2016

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2016

Net Margin

33rd percentile

-2.2%

Higher net margin than 33% of similar nonprofits.

2016 filings • NTEE E • <$500k nonprofits • Source year 2016

Top Officer Pay

73rd percentile

$0

Higher top officer pay than 73% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2016 filings • NTEE E • <$500k nonprofits • Source year 2016

Asset Growth

40th percentile

-1.2%

Faster asset growth than 40% of similar nonprofits.

2016 filings • NTEE E • <$500k nonprofits • Annualized from 2015 to 2016

Revenue Growth

11th percentile

-52%

Faster revenue growth than 11% of similar nonprofits.

2016 filings • NTEE E • <$500k nonprofits • Annualized from 2015 to 2016

Assets

Down

$115,139

Down $1,412 (-1.2%) from 2015

Net Assets

Down

$115,139

Down $1,412 (-1.2%) from 2015

Liabilities

-

No earlier filing loaded for comparison.

Revenue

Down

$63,094

Down $68,713 (-52%) from 2015

Expenses

Down

$64,506

Down $9,168 (-12%) from 2015

Net Income

Down

-$1,412

Down $59,545 (-102%) from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$150K$100K$50K$0Assets 2013: $46,109Liabilities 2013: $02013Assets 2014: $58,418Liabilities 2014: $02014Assets 2015: $116,551Net Assets 2015: $116,5512015Assets 2016: $115,139Net Assets 2016: $115,1392016Assets 2017: $126,527Net Assets 2017: $126,5272017Assets 2018: $132,155Net Assets 2018: $132,1552018Assets 2019: $136,737Net Assets 2019: $136,7372019Assets 2020: $162,615Net Assets 2020: $162,6152020Assets 2021: $156,596Net Assets 2021: $156,5962021Assets 2023: $154,971Net Assets 2023: $154,9712023Assets 2024: $166,978Net Assets 2024: $166,9782024

Highlighted filing

2016

Assets$115,139
Liabilities-
Net Assets$115,139

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2013: $84,000Expenses 2013: $37,891Net Income 2013: $46,1092013Revenue 2014: $52,146Expenses 2014: $39,837Net Income 2014: $12,3092014Revenue 2015: $131,807Expenses 2015: $73,674Net Income 2015: $58,1332015Revenue 2016: $63,094Expenses 2016: $64,506Net Income 2016: -$1,4122016Revenue 2017: $86,626Expenses 2017: $75,238Net Income 2017: $11,3882017Revenue 2018: $84,485Expenses 2018: $78,857Net Income 2018: $5,6282018Revenue 2019: $34,698Expenses 2019: $30,115Net Income 2019: $4,5832019Revenue 2020: $52,029Expenses 2020: $26,150Net Income 2020: $25,8792020Revenue 2021: $31,583Expenses 2021: $37,602Net Income 2021: -$6,0192021Revenue 2023: $84,312Expenses 2023: $76,999Net Income 2023: $7,3132023Revenue 2024: $84,748Expenses 2024: $72,740Net Income 2024: $12,0082024

Highlighted filing

2016

Revenue$63,094
Expenses$64,506
Net Income-$1,412
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Jul 10, 2017
Return Version
2016v3.0
Gross Receipts
$63,094
Mission and Program Overview

Mission

The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiati

Program Services

DescriptionGrantsExpenses
HELD DOMESTIC AND INTERNATIONAL MEETINGS, EVENTS AND TEACHING COURSES. EVENTS INCLUDED THE PRESENTATION OF ILROG GUIDELINES AT THE LA RADIOLOGICAL SOCIETY, A LYMPHOMA GUIDELINES COURSE FOR ISRAELI RADIATION ONCOLOGOISTS IN TEL AVIV, THE YONSEI LYMPHOMA SYMPOSIUM IN SEOUL, SOUTH KOREA, A STEERING COMMITTEE MEETING IN TORINO, ITALY, PRESENTATIONS AND LYMPHOMA PANEL AT ESTRO 2016, PRESENTATIONS, PANELS AND INSTRUCTION AT ASTRO 2016 IN BOSTON, MA, SCHOOL OF HEMATOLOGY COURSE IN VIENNA, AUSTRIA, TATA MEMORIAL HOSPITAL PRACTICUM IN MUMBAI, INDIA AND WORKSHOP AND PRESENTATION AT ISHL-10 IN COLOGNE, GERMANY.-$26,755
PUBLISHED SEVERAL GUIDELINES THAT WERE THE MOST DOWNLOADED PUBLICATIONS OF 2016 FROM THE INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY. (RED JOURNAL)-$10,846
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
JOACHIM YAHALOM MDChairmanPT$0--
LENA SPECHT MDVice-ChairmaPT$0--
TIM ILLIDGE MDSecretary/TrPT$0--
Filing and Contact Details

Filer

Filer Name
International Lymphoma Radiation
EIN
46-1995761
Phone
2126395999
Address
PO BOX 810, NEW YORK, NY 10021

Signing Officer

Name
Joachim Yahalom Md
Title
Chairman
Phone
2126395999
Signed
2017-07-10
Discuss with paid preparer
Yes

Preparer

Firm
COMER & COMPANY CPA'S LLC
Address
61 MAIN STREET, MIDDLETOWN, CT 06457-3408
Preparer
Thomas D Comer
Phone
8603462100
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 8

Refunds 3,000 total 3,000

Form 990-ez, Part I, Line 16

Expenses office expenses 390 311 155 311 5,061 1,655 bank fees 96 payroll processing fees 600 miscellaneous 177 total 8,756

Form 990-ez, Part II, Line 24

Prepaid expenses and deferred charges 540 540 total 540 540

Form 990-ez, Part III

The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiation therapy. - to initiate, support and conduct research that will further the understanding of radiotherapy in the treatment of lymphoma and that will improve the therapeutic ratio of using radiotherapy alone or in combination with other therapies.

Form 990-ez, Part III, Line 28

Held domestic and international meetings, events and teaching courses. Events included the presentation of ilrog guidelines at the la radiological society, a lymphoma guidelines course for israeli radiation oncologoists in tel aviv, the yonsei lymphoma symposium in seoul, south korea, a steering committee meeting in torino, italy, presentations and lymphoma panel at estro 2016, presentations, panels and instruction at astro 2016 in boston, ma, school of hematology course in vienna, austria, tata memorial hospital practicum in mumbai, india and workshop and presentation at ishl-10 in cologne, germany.

Raw XML Appendix143 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0INTERNATIONAL LYMPHOMA RADIATION
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine2Txt0INTERNATIONAL LYMPHOMA RADIATION
IRS990EZ/BooksInCareOfDetail/PhoneNum02126395999
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0351 E 51ST ST APT 14C
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine2Txt035 E 51ST ST APT 14C
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010022
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0116011
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0114599
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt050000
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-1412
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02160
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0116551
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0115139
IRS990EZ/GrossReceiptsAmt063094
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MembershipDuesAmt010094
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0116551
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0115139
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0116551
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0115139
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt012.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt18.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt28.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JOACHIM YAHALOM MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1LENA SPECHT MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2TIM ILLIDGE MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CHAIRMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE-CHAIRMA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SECRETARY/TR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0540
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0540
IRS990EZ/OtherExpensesTotalAmt08756
IRS990EZ/OtherRevenueTotalAmt03000
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATI
IRS990EZ/PrintingPublicationsPostageAmt0134
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HELD DOMESTIC AND INTERNATIONAL MEETINGS, EVENTS AND TEACHING COURSES. EVENTS INCLUDED THE PRESENTATION OF ILROG GUIDELINES AT THE LA RADIOLOGICAL SOCIETY, A LYMPHOMA GUIDELINES COURSE FOR ISRAELI RADIATION ONCOLOGOISTS IN TEL AVIV, THE YONSEI LYMPHOMA SYMPOSIUM IN SEOUL, SOUTH KOREA, A STEERING COMMITTEE MEETING IN TORINO, ITALY, PRESENTATIONS AND LYMPHOMA PANEL AT ESTRO 2016, PRESENTATIONS, PANELS AND INSTRUCTION AT ASTRO 2016 IN BOSTON, MA, SCHOOL OF HEMATOLOGY COURSE IN VIENNA, AUSTRIA, TATA MEMORIAL HOSPITAL PRACTICUM IN MUMBAI, INDIA AND WORKSHOP AND PRESENTATION AT ISHL-10 IN COLOGNE, GERMANY.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1PUBLISHED SEVERAL GUIDELINES THAT WERE THE MOST DOWNLOADED PUBLICATIONS OF 2016 FROM THE INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY. (RED JOURNAL)
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt026755
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt110846
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt053456
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt064506
IRS990EZ/TotalProgramServiceExpensesAmt037601
IRS990EZ/TotalRevenueAmt063094
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ILROG.COM
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt060094
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0131807
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt052146
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt084000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0328047
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt013094
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct01.00000
IRS990ScheduleA/PublicSupportPY170Pct01.00000
IRS990ScheduleA/PublicSupportTotal170Amt0328047
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt060094
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0131807
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt052146
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt084000
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0328047
IRS990ScheduleA/TotalSupportAmt0328047
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0REFUNDS 3,000 TOTAL 3,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EXPENSES OFFICE EXPENSES 390 311 155 311 5,061 1,655 BANK FEES 96 PAYROLL PROCESSING FEES 600 MISCELLANEOUS 177 TOTAL 8,756
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2PREPAID EXPENSES AND DEFERRED CHARGES 540 540 TOTAL 540 540
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATION THERAPY. - TO INITIATE, SUPPORT AND CONDUCT RESEARCH THAT WILL FURTHER THE UNDERSTANDING OF RADIOTHERAPY IN THE TREATMENT OF LYMPHOMA AND THAT WILL IMPROVE THE THERAPEUTIC RATIO OF USING RADIOTHERAPY ALONE OR IN COMBINATION WITH OTHER THERAPIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4HELD DOMESTIC AND INTERNATIONAL MEETINGS, EVENTS AND TEACHING COURSES. EVENTS INCLUDED THE PRESENTATION OF ILROG GUIDELINES AT THE LA RADIOLOGICAL SOCIETY, A LYMPHOMA GUIDELINES COURSE FOR ISRAELI RADIATION ONCOLOGOISTS IN TEL AVIV, THE YONSEI LYMPHOMA SYMPOSIUM IN SEOUL, SOUTH KOREA, A STEERING COMMITTEE MEETING IN TORINO, ITALY, PRESENTATIONS AND LYMPHOMA PANEL AT ESTRO 2016, PRESENTATIONS, PANELS AND INSTRUCTION AT ASTRO 2016 IN BOSTON, MA, SCHOOL OF HEMATOLOGY COURSE IN VIENNA, AUSTRIA, TATA MEMORIAL HOSPITAL PRACTICUM IN MUMBAI, INDIA AND WORKSHOP AND PRESENTATION AT ISHL-10 IN COLOGNE, GERMANY.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 8
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0JOACHIM YAHALOM MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CHAIRMAN
ReturnHeader/BusinessOfficerGrp/PhoneNum02126395999
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-07-10
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0INTERNATIONAL LYMPHOMA RADIATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0ONCOLOGY FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0INTE
ReturnHeader/Filer/EIN0461995761
ReturnHeader/Filer/PhoneNum02126395999
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 810
ReturnHeader/Filer/USAddress/CityNm0NEW YORK
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010021
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0D31367FC41E89A8981A0C177309F3D30AA93428A
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0D6C633D53EBDAE9AEB9E70686575D86E300443E1
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0522436535
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0COMER & COMPANY CPA'S LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt061 MAIN STREET
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0MIDDLETOWN
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CT
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0064573408
ReturnHeader/PreparerPersonGrp/PhoneNum08603462100
ReturnHeader/PreparerPersonGrp/PreparationDt02017-07-10
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0THOMAS D COMER
ReturnHeader/ReturnTs02017-08-08T08:39:34-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings